Infection Prevention and Control in Family Medicine: Current Practices, Challenges, and Future Directions
DOI:
https://doi.org/10.64813/ejmr.2026.080Keywords:
Cross Infection, Family Practice, Infection Control, Patient Safety, IPC practicesAbstract
Infection prevention and control (IPC) in family medicine is a fundamental aspect of primary healthcare, playing a key role in reducing the transmission of infectious diseases in community settings. This narrative review explores current IPC practices in outpatient and family medicine settings, identifies major challenges, and discusses future directions for improvement. A structured literature search was conducted using major databases, including PubMed, Scopus, Web of Science, and the Cochrane Library, focusing on studies related to IPC, antimicrobial resistance, and primary care infections. The review highlights that family medicine clinics face a high burden of infectious diseases, particularly respiratory, gastrointestinal, and skin infections. Core IPC measures such as hand hygiene, standard precautions, environmental cleaning, safe injection practices, and appropriate use of personal protective equipment remain the foundation of infection control. However, their implementation is often inconsistent due to resource limitations, training gaps, infrastructural constraints, and behavioral factors. The review also emphasizes the importance of antimicrobial stewardship and vaccination as integrated components of IPC. Lessons from the COVID-19 pandemic further underline the need for preparedness, telemedicine integration, and stronger infection control systems in primary care. Overall, strengthening IPC in family medicine requires coordinated efforts at clinical, organizational, and policy levels to improve patient safety and reduce the burden of infectious diseases and antimicrobial resistance globally.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Mehmood Ahmad, Farzand Ali

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.